ロード中...
Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. Currently, surgical resection, liver transplantation, and local ablation are considered curative therapeutic practices for HCC. The diagnosis of HCC without pathologic confirmation is achieved by analyzing serum...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4177612/ https://ncbi.nlm.nih.gov/pubmed/24252133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-1-10 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|